Application 012827

Type
NDA
Sponsor
CASPER PHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ROBINULGLYCOPYRROLATETABLET;ORAL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002ROBINUL FORTEGLYCOPYRROLATETABLET;ORAL2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N012827-001ROBINULGLYCOPYRROLATE1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982
N012827-002ROBINUL FORTEGLYCOPYRROLATE2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
N012827-001AA
N012827-002AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N012827-001ROBINUL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N012827-002ROBINUL FORTE2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N012827-001ROBINUL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N012827-002ROBINUL FORTE2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N012827-001ROBINUL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N012827-002ROBINUL FORTE2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N012827-001ROBINUL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N012827-002ROBINUL FORTE2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N012827-001ROBINUL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N012827-002ROBINUL FORTE2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982a50c72e98297…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 74 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N012827-001AA1d4dbc9d85df4…
2026-11-14 07:37:172026-10N012827-002AA1d4dbc9d85df4…
2026-10-15 13:18:302026-09N012827-001AA1c2088c7a36db…
2026-10-15 13:18:302026-09N012827-002AA1c2088c7a36db…
2026-09-14 22:38:342026-08N012827-001AA184e616aacf4f…
2026-09-14 22:38:342026-08N012827-002AA184e616aacf4f…
2026-08-18 06:07:402026-07N012827-001AA1caaa826d4ba7…
2026-08-18 06:07:402026-07N012827-002AA1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N012827-001AA1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N012827-002AA1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N012827-001AA131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N012827-002AA131067a03dcf5…
2025-08-23 18:47 UTC2025-08N012827-001AA16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N012827-002AA16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N012827-001AA1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N012827-002AA1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N012827-001AA1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N012827-002AA1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N012827-001AA103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N012827-002AA103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N012827-001AA12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N012827-002AA12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N012827-001AA15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N012827-002AA15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N012827-001AA1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N012827-002AA1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N012827-001AA1d06236e962d9…
2024-10-29 15:01 UTC2024-10N012827-002AA1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N012827-001AA179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N012827-002AA179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N012827-001AA1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N012827-002AA1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N012827-001AA11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N012827-002AA11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N012827-001AA18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N012827-002AA18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012827-001AA15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012827-002AA15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N012827-001AA15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N012827-002AA15d02ea3f76ae…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GlycopyrrolateGLYCOPYRROLATEBryant Ranch Prepack10ea264f-e157-4e13-9d79-b4228daf359d2026-02-17Warnings, Adverse reactionsExact identifier
application applno (NDA): 012827
application number: NDA012827
GlycopyrrolateGLYCOPYRROLATERising Pharma Holdings, Inc.58c4cb1f-59b8-4be9-a222-2264ca077d932025-12-03Warnings, Adverse reactionsExact identifier
application applno (NDA): 012827
application number: NDA012827
ndc (product): 16571-743
ndc (product): 16571-744

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 11 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16571-743GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
16571-743GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
16571-744GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
16571-744GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
59630-200RobinulGlycopyrrolateShionogi Inc.NDACurrent
59630-205Robinul ForteGlycopyrrolateShionogi Inc.NDACurrent
68788-8279GlycopyrrolateGlycopyrrolatePreferred Pharmaceuticals Inc.NDA AUTHORIZED GENERICCurrent
70199-007RobinulGlycopyrrolateCasper Pharma LLCNDACurrent
70199-007RobinulGlycopyrrolateCasper Pharma LLCNDACurrent
70199-008Robinul ForteGlycopyrrolateCasper Pharma LLCNDACurrent
70199-008Robinul ForteGlycopyrrolateCasper Pharma LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72198SUPPL2022-09-30
72168SUPPL2022-09-28
48242SUPPL2017-05-05
40683SUPPL2009-09-14
40682SUPPL2009-09-14
40681SUPPL2009-09-14
40680SUPPL2009-09-14
40679SUPPL2009-09-14
40678SUPPL2009-09-14
20038SUPPL2009-09-14
20037SUPPL2009-09-14
20036SUPPL2009-09-14
20035SUPPL2009-09-14
20034SUPPL2009-09-14
344SUPPL2003-08-06